Clara Health

Clara Health helps patients find suitable clinical trials from a database of over 50,000 clinical trials (as of May 2022). The company supports patients using a combination of its digital platform and human “trial navigators” that assist with finding suitable trials and completing the onboarding process. Clara’s recruitment platform helps speed up the recruitment process, with the company claiming a 2x–4x improvement in time to recruit, along with improving the diversity of clinical trials through its outreach and advocacy partnerships.

Clara Health also expanded into tools to support patients during clinical trials and after onboarding, through a service called Clara Care. The support is available 24/7 and is tailored to the patient population and behavioral characteristics. The key benefit for customers is higher patient retention rates and engagement.

From a compliance perspective, the platform is HIPAA, GDPR, and 21 CFR Part 11 compliant and incorporates encryption technology into its communication modules.

In March 2022, the company was acquired by M&B Sciences Inc.However, as per the agreement, Clara Health would continue to operate under its own brand but as a part of M&B Sciences.

Key customers and partnerships

As of May 2022, the company’s partners included Stanford Medicine, the University of California, San Francisco, Amylyx, and Finch. These partnerships help Clara tailor its platform to improve the patient experience, along with increasing the reach of the platform with underserved populations and patient groups, such as African American communities. The company noted that, as of June 2024, it had supported 50,000+ clinical trials.

Funding and financials

Clara Health was acquired in March 2022 by M&B Sciences, an African American-owned clinical research organization. The Clara Health platform was to be integrated with M&B’s existing patient recruitment platform Neighborhood Trials to increase its scale.